Pseudomonas vaccine - Inimmune
Alternative Names: INI-2002 adjuvanted Pseudomonas vaccine - InimmuneLatest Information Update: 03 Oct 2023
Price :
$50 *
At a glance
- Originator Inimmune
- Class Bacteriophages; Pseudomonas vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Pseudomonal infections
Most Recent Events
- 28 Sep 2023 Inimmune plans phase I clinical trial for Pseudomonas vaccine in early 2024
- 23 Feb 2021 Inimmune plans human clinical trial for Pseudomonal infections (Inimmune website, February 2021)
- 23 Feb 2021 Pseudomonas vaccine is available for licensing as of 23 Feb 2021. https://inimmune.com/investors/